Emerging market outlook: I want to confirm whether the main players scheduled to announce financial results will test a return

Fisco Japan · Apr 27 13:06

■週を通してエネルギー不足の地合い

今週の新興市場は反発。同時期の騰落率は、日経平均が+2.34％だったのに対して、グロース市場指数は+0.95％、グロース市場250指数は+0.92％と日経平均よりも小幅な反発に留まった。週初は半導体関連銘柄を中心に米ハイテク株が弱い動きとなったことから、プライム市場の半導体株を中心に利益確定売りが先行。投資家心理が悪化したことで、グロース市場は年初来安値を更新する銘柄の投げ売りが目立った。押し目を狙うような積極的な投資家は不在となったことから、グロース市場の売買代金は5営業日連続で1000億円を下回った。週末にかけては米ハイテク株上昇などを材料に自律反発的な買いが入ったことから、グロース市場指数、グロース市場250指数ともに週間ベースでは反発となったが、週を通してエネルギー不足の地合いとなった。

個別銘柄では、東京都世田谷区による顔認証勤怠システム「AIZE」の採用や、グループ会社のゼロフィールドが業務提携先と連携を進め、米国にデータセンターを増設などと発表したトリプルアイズ＜5026＞が急騰。L is B＜145A＞は、横井社長CEOが投資家向けチャンネルで「黒字維持しながら成長」と強調したことで買われた。リンカーズ＜5131＞がオンデック＜7360＞と業務提携し、M&A支援、プラットフォーム開発、ビジネスマッチングの3領域で相互に協力すると発表し買われた。一方、決算が嫌気されてシーユーシー＜9158＞が上場来安値を更新したほか、ティーケーピー＜3479＞、カバー＜5253＞、トライト＜9164＞など主力銘柄も総じて売られた。

なお、4月24日にグロースへ上場したレジル＜176A＞の初値は公開価格を0.4％上回る1205円、25日に同じくグロースへ上場したコージンバイオ＜177A＞の初値は公開価格を6.8％上回る2030円となった。その後、レジルは初値を上回って推移したが、コージンバイオは週末に急落して初値を下回った。

■再来週は主力処の決算発表が多数予定、IPOは空白期間入り

来週から再来週にかけての新興市場は、プライム市場同様、決算発表銘柄中心の地合いとなりそうだ。好決算銘柄が素直に買われる地合いとなれば、グロース市場指数やグロース市場250指数も堅調推移となりそうだが、今週材料が出たQPS研究所＜5595＞ですら買いが続かなったことから、投資家心理を刺激する核となる銘柄が出るかは微妙なところだ。

再来週は9日にサンウェルズ＜9229＞、BASE＜4477＞、10日に弁護士ドットコム＜6027＞、GMOフィナンシャルゲート＜4051＞とグロース市場Core指数構成銘柄など主力処の決算発表が予定されている。今週は主力処も週間騰落率ランキング値下がり上位に複数社が名を連ねる厳しい状況だった。投資家心理が悪化していることで物色意欲は弱く、売買代金は細っている。足元の地合いを考慮すると、グロース市場全体の底入れを試すのはまだ先と考える。まずは、決算発表前後の主力株で戻りを試す銘柄が現れるかを確認したい。なお、新規株式公開（IPO）は、5月28日上場予定の学びエイド＜184A＞登場まで空白期間となる。

■The state of lack of energy throughout the week

Emerging markets rebounded this week. As for the gain/fall rate for the same period, the Nikkei Average was +2.34%, while the Growth Market Index was +0.95% and the Growth Market 250 Index was +0.92%, which was a slight rebound from the Nikkei Average. Since US high-tech stocks, mainly semiconductor-related stocks, showed weak movements at the beginning of the week, profit-taking sales centered on semiconductor stocks in the prime market took the lead. As investor sentiment deteriorated, dumping of stocks breaking year-to-date lows was conspicuous in the growth market. Since there were no active investors aiming for promotion, trading prices in the growth market fell below 100 billion yen for 5 consecutive business days. Since autonomous repulsive purchases were made over the weekend due to rising US high-tech stocks, etc., both the Growth Market Index and the Growth Market 250 Index rebounded on a weekly basis, but there was a shortage of energy throughout the week.

Among individual brands, Triple Eyes (5026), which adopted the face recognition attendance system “AIZE” by the Setagaya-ku district of Tokyo and announced that the group company Zero Field promoted cooperation with business partners and expanded data centers in the United States, etc., skyrocketed. L is B (145A) was bought because President and CEO Yokoi emphasized “growth while maintaining a surplus” on an investor channel. It was announced that Linkers ＜5131＞ will form a business alliance with OnDc ＜7360＞ and cooperate with each other in the 3 areas of M&A support, platform development, and business matching, and it was purchased. Meanwhile, financial results were disgusting and CCC ＜9158＞ updated the low price since listing, and main brands such as TKP ＜3479＞, cover ＜5253＞, and tright ＜9164＞ were also sold in general.

Note, the initial price of Regil ＜176A＞, which was listed on Growth on 4/24, was 1205 yen, which was 0.4% above the public price, and the initial price of Cojin Bio ＜177A＞, which was also listed on Growth on the 25th, was 2030 yen, which was 6.8% above the public price. After that, Regil remained above the initial price, but Cojin Bio plummeted over the weekend and fell below the initial price.

■Next week, many financial results announcements for the main companies are scheduled, and IPOs will enter a blank period

Emerging markets from next week to next week are likely to be centered around stocks announcing financial results, similar to the prime market. If stocks with good financial results are honestly bought, it seems that the Growth Market Index and Growth Market 250 Index will also be on a steady trend, but since buying did not continue even at the QPS Research Institute (5595), where materials came out this week, it is a delicate matter whether core stocks that stimulate investor sentiment will come out.

Next week, financial results for the main players such as Sunwells ＜9229＞, BASE ＜4477＞ are scheduled to be announced on the 9th, lawyer.com ＜6027＞, GMO Financial Gate ＜4051＞, and Growth Market Core Index constituent stocks on the 10th. This week, the main office was also in a tough situation, with multiple companies listed at the top of the weekly gain/fall rate rankings. As investor sentiment has deteriorated, shopping motivation is weak, and trading prices are shrinking. Considering the current situation, I think it is still a long way to test the bottom of the growth market as a whole. First, I would like to check whether stocks that will test a return will appear in the main stocks before and after the financial results are announced. Note that the initial public offering (IPO) will be a blank period until the introduction of Learning Aid (184A), which is scheduled to be listed on 5/28.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

新興市場見通し：決算発表予定の主力処が戻りを試すか確認したいところ

Emerging market outlook: I want to confirm whether the main players scheduled to announce financial results will test a return

Risk Disclaimer

Statement